Cargando…
Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared as pandemic by World Health Organization (WHO) with increasing morbidity (more than 4.6 million patients) and mortality (300,000 deaths). The world-wide target o...
Autores principales: | Faizul Huq, AKM, Rahman, Md Fashiur, Islam, Md Azizul, Iqbal, Syed A, Rahman, Azizur, Abdullah, Syed Abul Hassan Md, Al Mahtab, Mamun, Akbar, Sheikh MF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376598/ https://www.ncbi.nlm.nih.gov/pubmed/32742970 http://dx.doi.org/10.5005/jp-journals-10018-1316 |
Ejemplares similares
-
Therapeutic Endoscopy during COVID-19 Pandemic: An Observational Study from Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2020) -
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh
por: Islam, Md Azizul, et al.
Publicado: (2020) -
Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
por: Bhuyan, Muhammad AR, et al.
Publicado: (2020) -
Clinical Manifestations of Hospitalized COVID-19 Patients in Bangladesh: A 14-day Observational Study
por: Shaha, Modhusudon, et al.
Publicado: (2021) -
High Prevalence of Wilson's Diseases with Low Prevalence of Kayser–Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh
por: Choudhury, Nuzhat, et al.
Publicado: (2019)